Literature DB >> 6828336

Factors affecting the lipid and apolipoprotein levels of cord sera.

D M Lane, W J McConathy.   

Abstract

In studying the human lipid transport system as it changes from the fetal to the adult form, data were collected on cord sera levels of lipids and apolipoproteins (A-I, A-II, ApoB, C-I, C-II, C-III, ApoD, and ApoE) from infants whose lipid metabolism might have been modified by a variety of factors present before, at, or after delivery. The results clearly indicated that many factors affect the levels of both lipids and apolipoproteins at birth. Method of delivery had little effect except in relation to either fetal immaturity (increased total cholesterol) or fetal stress (increased triglycerides). Birth weight was related to changes in free cholesterol, C-I, C-III, and ApoE levels. Gestational age had greater impact upon both serum lipids and apolipoproteins. With increasing fetal maturity, total cholesterol, free cholesterol, A-II, C-II, and ApoE progressively fell whereas triglyceride and ApoD rose. A variety of clinical disorders were also associated with changes in serum lipid and apolipoproteins. Anencephaly produced marked increases in both free and total cholesterol as well as most apolipoproteins. Significant reductions in triglyceride and ApoD levels were found in infants who subsequently became ill in the postnatal period with problems relating to carbohydrate metabolism (e.g., infants of diabetic mothers). Infants with respiratory distress were found to have decreased levels of total cholesterol and ApoB, both of which are increased in prematurity, a condition with which respiratory distress (RD) is usually associated. The changes in cord sera lipid and apolipoprotein levels found in a variety of clinical situations may provide new diagnostic approaches to postnatal problems arising in the newborn.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6828336     DOI: 10.1203/00006450-198302000-00001

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch signaling.

Authors:  Mohanasundari Pajaniappan; Nancy K Glober; Simone Kennard; Hua Liu; Ning Zhao; Brenda Lilly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

2.  Effect of Preterm Birth on Postnatal Apolipoprotein and Adipocytokine Profiles.

Authors:  Gunnel Hellgren; Eva Engström; Lois E Smith; Chatarina Löfqvist; Ann Hellström
Journal:  Neonatology       Date:  2015-04-29       Impact factor: 4.035

3.  Cord Blood Advanced Lipoprotein Testing Reveals an Interaction between Gestational Diabetes and Birth-Weight and Suggests a New Early Biomarker of Infant Obesity.

Authors:  Francisco Algaba-Chueca; Elsa Maymó-Masip; Mónica Ballesteros; Albert Guarque; Alejandro Majali-Martínez; Olga Freixes; Núria Amigó; Sonia Fernández-Veledo; Joan Vendrell; Ana Megía
Journal:  Biomedicines       Date:  2022-04-29

4.  DNA methylations of MC4R and HNF4α are associated with increased triglyceride levels in cord blood of preterm infants.

Authors:  Eun Jin Kwon; Hye Ah Lee; Young-Ah You; Hyesook Park; Su Jin Cho; Eun Hee Ha; Young Ju Kim
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 5.  Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging.

Authors:  German Perdomo; H Henry Dong
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

6.  Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain.

Authors:  Sonia Do Carmo; Jean-Claude Forest; Yves Giguère; André Masse; Julie Lafond; Eric Rassart
Journal:  Reprod Biol Endocrinol       Date:  2009-09-02       Impact factor: 5.211

7.  Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice.

Authors:  Corine Martineau; Ouafa Najyb; Céline Signor; Éric Rassart; Robert Moreau
Journal:  Metabolism       Date:  2016-05-19       Impact factor: 8.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.